A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Clinical trial NCT05495061 · COMPLETED
Trial details
- NCT number
- NCT05495061
- Sponsor
- Santen Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-09
- Primary completion
- 2023-04-18
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.